The DSM-IV panic disorder field trial: Panic attack frequency and functional disability

Anxiety ◽  
1996 ◽  
Vol 2 (4) ◽  
pp. 157-166 ◽  
Author(s):  
Abby J. Fyer ◽  
Wayne Katon ◽  
Michael Hollifield ◽  
Hilary Rassnick ◽  
Salvatore Mannuzza ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Field Trial ◽  
Panic Attack ◽  
Functional Disability ◽  
Attack Frequency ◽  
Dsm Iv

Recognising panic disorder

1995 ◽  
Vol 10 (S2) ◽  
pp. 61s-63s ◽  
Author(s):  
DF Klein
Keyword(s):  
Panic Disorder ◽  
Panic Attack ◽  
Accident And Emergency ◽  
Patient Will ◽  
Emergency Units ◽  
Dsm Iv ◽  
Chest Pains

The most important feature of panic disorder is the existence of a discrete crescendo of distress that peaks very quickly and disappears quickly (DSM-IV, 1994). However, a patient will frequently erroneously say that the panic lasted hours. When a person has a panic attack they feel tremendously overwhelmed and often seek help in accident and emergency units. An estimated one in three people who present at these units with chest pains has symptoms consistent with panic disorder (Fleet et al, 1994).

Panic Disorder With Nocturnal Panic Attacks: Symptoms and Comorbidities

2007 ◽  
Vol 23 (3) ◽  
pp. 195-200 ◽  
Author(s):  
Gökhan Sarísoy ◽  
Ömer Böke ◽  
Ali C. Arík ◽  
Ahmet R. Şahin
Keyword(s):  
Panic Disorder ◽  
Beck Depression Inventory ◽  
Panic Attack ◽  
Respiratory Symptoms ◽  
Psychiatric Symptoms ◽  
Panic Attacks ◽  
Symptom Checklist ◽  
Scale Scores ◽  
Dsm Iv ◽  
The Relationship

AbstractThe aim of this study was to determine the relationship between nocturnal panic attacks and comorbidities, clinical variables and panic attack symptoms. One hundred and six consecutive patients with DSM-IV panic disorder were enrolled in the study. The patients were divided into two groups depending on the presence of nocturnal panic attacks. Comorbidities were diagnosed with the help of SCID-I and SCID-II. The groups were compared using the Beck Depression Inventory, State-Trait Anxiety Inventory and Symptom Checklist. Nocturnal panic attacks were not related to comorbidities or age at the onset of the disease. The scores from the Beck Depression Inventory, general scores from the Symptom Checklist, somatization, obsession-compulsion, interpersonal sensitivity and anger-hostility sub-scale scores were higher in the nocturnal panic attack group. Patients with nocturnal panic attacks experience more frequent respiratory symptoms, suggesting that nocturnal panic attacks may be related to respiratory symptoms. Our findings demonstrate that patients with nocturnal panic attacks have more respiratory symptoms of panic, depressive and other psychiatric symptoms than the no nocturnal panic group.

scholarly journals Do Panic Symptoms Affect the Quality of Life and Add to the Disability in Patients with Bronchial Asthma?

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
A. D. Faye ◽  
S. Gawande ◽  
R. Tadke ◽  
V. C. Kirpekar ◽  
S. H. Bhave ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Panic Disorder ◽  
Bronchial Asthma ◽  
Functional Disability ◽  
Poor Quality ◽  
Panic Attacks ◽  
Disability Score ◽  
Dsm Iv ◽  
Panic Symptoms

Background. Anxiety and panic are known to be associated with bronchial asthma with variety of impact on clinical presentation, treatment outcome, comorbidities, quality of life, and functional disability in patients with asthma. This study aims to explore the pattern of panic symptoms, prevalence and severity of panic disorder (PD), quality of life, and disability in them.Methods. Sixty consecutive patients of bronchial asthma were interviewed using semistructured proforma, Panic and Agoraphobia scale, WHO Quality of life (QOL) BREF scale, and WHO disability schedule II (WHODAS II).Results. Though 60% of the participants had panic symptoms, only 46.7% had diagnosable panic attacks according to DSM IV TR diagnostic criteria and 33.3% had PD. Most common symptoms were “sensations of shortness of breath or smothering,” “feeling of choking,” and “fear of dying” found in 83.3% of the participants. 73.3% of the participants had poor quality of life which was most impaired in physical and environmental domains. 55% of the participants had disability score more than a mean (18.1).Conclusion. One-third of the participants had panic disorder with significant effect on physical and environmental domains of quality of life. Patients with more severe PD and bronchial asthma had more disability.

Prevalence of Panic Disorder in Cardiac Outpatients

1997 ◽  
Vol 42 (2) ◽  
pp. 185-190 ◽  
Author(s):  
Amit Morris ◽  
Bilan Baker ◽  
Gerald M Devins ◽  
Colin M Shapiro
Keyword(s):  
Heart Disease ◽  
Family History ◽  
Panic Disorder ◽  
Cardiac Symptoms ◽  
Dsm Iv

Objective: To evaluate outpatients from Toronto-area cardiology clinics for panic disorder (PD) and investigate differences between patients with and without PD. Method: Participants were diagnosed using both standard DSM-IV criteria and an altered formulation that identified a more fearful panic group. Results: There was a prevalence of panic disorder (12.5%) in cardiac outpatients in keeping with previous studies. Patients with PD did not differ significantly from other patients with regard to the presence of significant heart disease. The higher prevalence of palpitations found in patients who met criteria for PD compared with those who did not reflects previous findings. PD cases did not differ significantly in family history from respondents without the disorder, but the more fearful group did (P < 0.05). Conclusion: PD often presents with cardiac symptoms, especially palpitations, and is often comorbid with heart disease.

scholarly journals Double-blind clonazepam vs placebo in panic disorder treatment

2000 ◽  
Vol 58 (4) ◽  
pp. 1025-1029 ◽  
Author(s):  
ALEXANDRE MARTINS VALENÇA ◽  
ANTONIO EGIDIO NARDI ◽  
ISABELLA NASCIMENTO ◽  
MARCO A. MEZZASALMA ◽  
FABIANA L. LOPES ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Rating Scale ◽  
Panic Attacks ◽  
Fixed Dose ◽  
Fisher Exact Test ◽  
Double Blind ◽  
Exact Test ◽  
Dsm Iv ◽  
Disorder Treatment ◽  
Hamilton Rating Scale

OBJECTIVE: To assess the effectiveness of clonazepam, in a fixed dose (2 mg/day), compared with placebo in the treatment of panic disorder patients. METHOD: 24 panic disorder patients with agoraphobia were randomly selected. The diagnosis was obtained using the structured clinical interview for DSM-IV . All twenty-four subjects were randomly assigned to either treatment with clonazepam (2 mg/day) or placebo, during 6 weeks. Efficacy assessments included: change from baseline in the number of panic attacks; CGI scores for panic disorder; Hamilton rating scale for anxiety; and panic associated symptoms scale. RESULTS: At the therapeutic endpoint, only one of 9 placebo patients (11.1%) were free of panic attacks, compared with 8 of 13 (61.5%) clonazepam patients (Fisher exact test; p=0,031). CONCLUSION: the results provide evidence for the efficacy of clonazepam in panic disorder patients.

scholarly journals Coronavirus disease-19 Pandemic-Induced Panic Disorder

2021 ◽  
Vol 9 (T3) ◽  
pp. 237-239
Author(s):  
Muhammad Surya Husada ◽  
Mustafa M. Amin ◽  
Munawir Saragih
Keyword(s):  
Infectious Disease ◽  
Case Report ◽  
Panic Disorder ◽  
Panic Attack ◽  
Respiratory Symptoms ◽  
Panic Attacks ◽  
Psychosocial Burden ◽  
Her Family ◽  
Common Diagnosis ◽  
The Individual

Background: COVID-19 is a newly emerging infectious disease which is found to be caused by SARS-2. COVID-19 pandemic has spread worldwide causing a rapidly increasing number of mental disorders cases, primarily anxiety disorder. Since majority of panic disorder patients are present with great anxiety in response to their physical or respiratory symptoms, support and encouragement from psychiatrist or therapist are fundamental to alleviate the severity of the symptoms. Case Report: We reported a case of COVID-19 induced panic disorder in a woman, 52 years old, batak tribe who started to experience multiple panic attacks since one of her family members was confirmed to be Covid-10 positive. Conclusion: In general, panic disorder is a common diagnosis, but this case appeared to be interesting as it is induced by COVID-19 pandemic. As in this case, the individual who experienced multiple panic attack is not even a COVID-19 patient but has one of her family member affected by the virus. A wide body of evidence has shown that this pandemic massively contributes to worsening of psychosocial burden in nationwide.

Fear of Autonomic Arousal and Use of Coping Strategies as Predictors of Agoraphobic Avoidance in Panic Disorder

1998 ◽  
Vol 15 (4) ◽  
pp. 228-236 ◽  
Author(s):  
Patricia Rayment ◽  
Jeff Richards
Keyword(s):  
Panic Disorder ◽  
Coping Strategies ◽  
Significant Proportion ◽  
Panic Attacks ◽  
Autonomic Arousal ◽  
Negative Cognitions ◽  
Considerable Controversy ◽  
Dsm Iv ◽  
Panic Symptoms ◽  
Behavioural Strategies

Despite the very significant proportion of people with panic disorder who have accompanying agoraphobia, there is considerable controversy about the variables that influence the development of this avoidance behaviour. This study investigated whether degree of avoidance is a function of extent of fear and prevalence of negative cognitions about autonomic arousal symptoms and whether the use of, and confidence in, behavioural strategies to cope with panic sensations also influences agoraphobic avoidance. Thirty-nine people who met DSM-IV criteria for panic disorder completed questionnaires measuring fear and negative cognitions about autonomic arousal and panic sensations, and a questionnaire measuring their use of largely behavioural strategies to cope with panic attacks. Fear of autonomic arousal and negative cognitions in response to the occurrence of these arousal symptoms were jointly related to situational avoidance. There was little relationship between the use of, and confidence in, panic coping strategies and less agoraphobic avoidance, although simply allowing panic symptoms to develop and pass predicted less avoidance. The results were interpreted as providing an empirical basis for treatment that reduces fear of panic sensations and allows their experience to be tolerated while preventing escape and avoidance of situations in which panic occurs. There was little evidence that additional teaching of behavioural coping strategies would be useful in reducing agoraphobic avoidance.

Recurrent episodes of intense fear, shortness of breath, racing heart, and sweating

2021 ◽  
pp. 111-118
Author(s):  
Christina L. Macenski
Keyword(s):  
Panic Disorder ◽  
Gold Standard ◽  
Panic Attack ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Behavioral Therapy ◽  
Panic Attacks ◽  
Shortness Of Breath ◽  
Intense Fear ◽  
Therapy Intervention ◽  
Norepinephrine Reuptake

Panic disorder consists of recurrent, unexpected panic attacks accompanied by persistent worry about future attacks and/or a maladaptive change in behavior related to the attacks. A panic attack is defined as an abrupt surge of intense fear or discomfort that reaches a peak within minutes that occurs in conjunction with several other associated symptoms such as palpitations, sweating, trembling, shortness of breath, and chest pain. Features of panic disorder that are more common in adolescents than in adults include less worry about additional panic attacks and decreased willingness to openly discuss their symptoms. All patients with suspected panic disorder should undergo a medical history, physical examination, and laboratory workup to exclude medical causes of panic attacks. Cognitive behavioral therapy (CBT) including interoceptive exposures is the gold standard therapy intervention. Medications including selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) can also help reduce symptoms.

Rehabilitation techniques

2012 ◽  
pp. 1399-1403
Author(s):  
W. Rössler
Keyword(s):  
Functional Disability ◽  
Social Role ◽  
Psychiatric Rehabilitation ◽  
Environmental Problems ◽  
The People ◽  
Major Interest ◽  
Icd 10 ◽  
Dsm Iv ◽  
Illness Model ◽  
Clinical Conditions

The goal of psychiatric rehabilitation is to help disabled individuals to establish the emotional, social, and intellectual skills needed to live, learn, and work in the community with the least amount of professional support. Rehabilitation practice has changed the perception of mental illness. Enabling disabled people to live a normal life in the community causes a shift away from a focus on an illness model towards a model of functional disability. As such, other outcome measures aside from clinical conditions become relevant. Social role functioning including social relationship, work, and leisure as well as quality of life and family burden are of major interest for the people affected living in the community. The relevance of psychosocial and environmental problems is reflected in the DSM-IV and ICD-10. Axis IV of DSM-IV and codes Z55–Z65 and Z73 of ICD-10 are assigned for reporting psychosocial and environmental problems that may affect the diagnosis, treatment, and prognosis of mental disorders.

Sign in / Sign up

Export Citation Format

Share Document